Φορτώνει......
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis
BACKGROUND: In chronic diseases such as multiple sclerosis requiring lifelong treatment, studies on long-term outcomes are important. OBJECTIVE: To assess disability and magnetic resonance imaging-related outcomes in relapsing multiple sclerosis patients from a Phase 2 study of fingolimod 10 or more...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mult Scler J Exp Transl Clin |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7132565/ https://ncbi.nlm.nih.gov/pubmed/32284874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320907951 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|